Safety and efficacy of brentuximab vedotin in combination with AVD in stage II-IV HIV-associated classical Hodgkin lymphoma: Results of the phase 2 study, AMC 085 Meeting Abstract
| Authors: | Rubinstein, P. G.; Moore, P. C.; Bimali, M.; Chadburn, A.; Cesarman, E.; Rudek, M.; Ratner, L.; Ambinder, R. F.; Henry, D. H.; Barta, S. K.; Ghesquieres, H.; Coppo, P.; Delobel, P.; Boue, F.; Galicier, L.; Ramos, J. C.; Reid, E. G.; Sharon, E.; Mounier, N.; Besson, C.; Noy, A. |
| Abstract Title: | Safety and efficacy of brentuximab vedotin in combination with AVD in stage II-IV HIV-associated classical Hodgkin lymphoma: Results of the phase 2 study, AMC 085 |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000518218500558 |
| DOI: | 10.1182/blood-2019-126787 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 130 -- Source: Wos |
